LemnaTec which has developed a high-throughput research platform and agricultural analysis software, has received a $5.6 million equity investment from Anterra Capital. This news arrives after a successful financing round led by DEWB, the German private equity firm. According to the company, they are now one of the largest providers of systems and software for image capture and data processing for agricultural use. LemnaTec plans to use the proceeds to fuel further growth and global market expansion.
“The partnership between Anterra and LemnaTec will help accelerate our expansion, particularly in the USA, and allow us to extend our software and service capabilities,” said Dirk Vandenhirtz, CEO and founder of LemnaTec. “We are now backed by two strong institutional investors and I am very confident that Anterra will energetically support our continued growth with their technology expertise and extensive industry contacts.”
Founded in 1998, LemnaTec has developed a wide product line specializing in platforms and analysis software for Ag chemistry, plant cultivation, bio-tech and pharmaceutical research. It sells a specialized hardware and software designed to take and process digital images of plants in order to produce superior phenotypic data. The company uses it’s Scanalyzer product line to improve the performance of phenotyping results in research and development. Their line includes low throughput systems for lab monitoring and high throughput systems for monitoring large scale greenhouse and open field operations and uses a wide range of image acquisition and analysis platforms to suit most biological image analysis needs. The company also utilizes its LemnaLauncher, the main framework granting access to all LemnaTec software across the entire product range. All gathered research imagery and metadata are accessible through the customizable software platform provided by the company, providing a full circle implementation and data gathering workflow.
The new influx of financing comes just after the company celebrates several benchmarks in the last few months such as opening an office in St. Louis, MO and breaking ground on the construction of a high output field based phenotyping facility in the UK.